SCOPUS 정보 검색 플랫폼

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 234-

A case report of nephrotic syndrome due to intake of certolizumab pegol in a patient with crohn's disease

(2) Leong, Jennifer a Fung Liu, Blanche a

a NORTH SHORE UNIVERSITY HOSPITAL (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; CERTOLIZUMAB PEGOL; CREATININE; DIPHENHYDRAMINE; DIURETIC AGENT; ETANERCEPT; INFLIXIMAB; MERCAPTOPURINE; PARACETAMOL; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; CASE REPORT; CREATININE BLOOD LEVEL; CROHN DISEASE; DRUG WITHDRAWAL; FACE EDEMA; FEMALE; FOCAL GLOMERULONEPHRITIS; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNOTHERAPY; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; LEG EDEMA; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; TREATMENT FAILURE;

CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MIDDLE AGED; NEPHROTIC SYNDROME; POLYETHYLENE GLYCOLS;

EID: 73849085328 PISSN: 00029270 EISSN: 15720241 Source Type: Journal
DOI: 10.1038/ajg.2009.500 Document Type: Letter

Times cited : (7)

References (7)

1
- 27944461472
- Infiximabandnephroticsyndrome
- Chin G, Luxton G, Harvey JM. Infiximabandnephroticsyndrome. Nephrol Dial Transplant 2005;20:2824-2826
- (2005) Nephrol Dial Transplant , vol.20 , pp. 2824-2826
- Chin, G.¹ Luxton, G.² Harvey, J.M.³

2
- 0038108777
- Nephrotic syndrome as a complication oflanti-TNflalpha in a patient with rheumatoid arthritis
- den Broeder A A, Assmann K J,van Riel P L et al. Nephrotic syndrome as a complication oflanti-TNflalpha in a patient with rheumatoid arthritis. Neth J Med 2003;63:137-141
- (2003) Neth J Med , vol.63 , pp. 137-141
- Den Broeder, A.A.¹ Assmann, K.J.² Van Riel, P.L.³

3
- 26044483813
- Development of glomerulonephritis during anti-TNflalpha therapy for rheumatoid arthritis
- Stokes M B, Foster K, Markowitz G S et al. Development of glomerulonephritis during anti-TNflalpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 2005;20:1400-1406
- (2005) Nephrol Dial Transplant , vol.20 , pp. 1400-1406
- Stokes, M.B.¹ Foster, K.² Markowitz, G.S.³

4
- 34447523749
- PRECISE 1 Study Investigators. Certolizumab pegol for the treatment of Crohn's disease
- Sandborn W J, Feagan B G, Stoinov S et al. PRECISE 1 Study Investigators. Certolizumab pegol for the treatment of Crohn's disease. N Engl J Med 2007; 357: 228-238
- (2007) N Engl J Med , vol.357 , pp. 228-238
- Sandborn, W.J.¹ Feagan, B.G.² Stoinov, S.³

5
- 24144483087
- A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of crohn's disease
- DOI 10.1053/j.gastro.2005.06.064, PII S0016508505013521
- Schreiber S, Rutgeerts P, Fedorak R N et al. CDP870 Crohn's Disease Study Group. A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease. Gastroenterology 2005;129:807-818 (Pubitemid 41242673)
- (2005) Gastroenterology , vol.129 , Issue.3 , pp. 807-818
- Schreiber, S.¹ Rutgeerts, P.² Fedorak, R.N.³ Khaliq-Kareemi, M.⁴ Kamm, M.A.⁵ Boivin, M.⁶ Bernstein, C.N.⁷ Staun, M.⁸ Thomsen, O.O.⁹ Innes, A.¹⁰

6
- 34447515607
- PRECISE 2 Study Investigators. Maintenance therapy with certolizu-mab pegol for Crohn's disease
- Schreiber S, Khaliq-Kareemi M, Lawrance IC et al. PRECISE 2 Study Investigators. Maintenance therapy with certolizu-mab pegol for Crohn's disease. N Engl J Med 2007;357:239-259
- (2007) N Engl J Med , vol.357 , pp. 239-259
- Schreiber, S.¹ Khaliq-Kareemi, M.² Lawrance, I.C.³

7
- 60349103428
- System atic review: The eficacy and safety of certolizumab pegol in Crohn's disease
- Shao L M, Chen M Y, Chen Q Y et al.System atic review: the eficacy and safety of certolizumab pegol in Crohn's disease. Aliment Pharmacol Ter 2009;29:605-614
- (2009) Aliment Pharmacol ter , vol.29 , pp. 605-614
- Shao, L.M.¹ Chen, M.Y.² Chen, Q.Y.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.